Cargando…
HDL from an Alzheimer's disease perspective
PURPOSE OF REVIEW: We review current knowledge regarding HDL and Alzheimer's disease, focusing on HDL's vasoprotective functions and potential as a biomarker and therapeutic target for the vascular contributions of Alzheimer's disease. RECENT FINDINGS: Many epidemiological studies hav...
Autores principales: | Button, Emily B., Robert, Jérôme, Caffrey, Tara M., Fan, Jianjia, Zhao, Wenchen, Wellington, Cheryl L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530968/ https://www.ncbi.nlm.nih.gov/pubmed/30946049 http://dx.doi.org/10.1097/MOL.0000000000000604 |
Ejemplares similares
-
Senescent cells in the development of cardiometabolic disease
por: Postmus, Andrea C., et al.
Publicado: (2019) -
CRISPR: a promising tool for lipid physiology and therapeutics
por: Furgurson, Mia, et al.
Publicado: (2019) -
Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application
por: Struik, Dicky, et al.
Publicado: (2019) -
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
Publicado: (2020) -
CC-Chemokine Ligand 2 (CCL2) Suppresses High Density Lipoprotein (HDL) Internalization and Cholesterol Efflux via CC-Chemokine Receptor 2 (CCR2) Induction and p42/44 Mitogen-activated Protein Kinase (MAPK) Activation in Human Endothelial Cells
por: Sun, Run-Lu, et al.
Publicado: (2016)